Arkolith/Insider Trading/EFTR/Form 4

Worland Stephen T

Chief Executive Officer, DirectoreFFECTOR Therapeutics, Inc. (EFTR) · full profile →Form 4 · filed Jan 19, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 17, 2023Grant(A)1.0M—$01.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-004053) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML